trial

Biocollection on Peripheral Inflammation

NCTId NCT05934474
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Recruiting
Enrollment 300 (estimated)
Sponsored by Nantes University Hospital
Primary completion 2026-08-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
300 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2024-03-19
Primary completion
2026-08-02
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Peripheral venipuncture blood sampling, as part of standard care proceduresInterview with a psychiatrist

Sponsors

Nantes University HospitalLead Sponsor
CR2TI, INSERM, UMR1064Collaborator

Investigators

1
Anne SauvagetPrincipal Investigator

Sites

1 total
Nantes, France

Facts & assertions

4 sourced
Enrollment
300
Phase
NA
Primary Completion Date
2026-08-02
Status
RECRUITING
relationships
The graph out of here
drug
Peripheral venipuncture blood sampling, as part of standard care procedures
drug
Interview with a psychiatrist
drug
lead_sponsor
Nantes University Hospital
company
collaborator
CR2TI, INSERM, UMR1064
company
indication
Bipolar Disorder
indication
Bipolar Disorder I
indication
Psychotic Disorders
indication
investigator
Anne Sauvaget
person